HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Community Trust & Investment Co.

Community Trust & Investment Co. boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,663 shares of the company’s stock after buying an additional 452 shares during the period. Community Trust & Investment Co.’s holdings in HCA Healthcare were worth $14,051,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in HCA. Norges Bank acquired a new stake in HCA Healthcare in the fourth quarter worth $840,286,000. GAMMA Investing LLC increased its holdings in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company’s stock valued at $5,887,850,000 after purchasing an additional 1,699,713 shares during the period. Royal London Asset Management Ltd. increased its holdings in shares of HCA Healthcare by 62.0% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock valued at $450,461,000 after purchasing an additional 574,239 shares during the period. Barclays PLC increased its holdings in shares of HCA Healthcare by 85.7% during the fourth quarter. Barclays PLC now owns 1,061,891 shares of the company’s stock valued at $318,727,000 after purchasing an additional 489,916 shares during the period. Finally, Principal Financial Group Inc. increased its holdings in shares of HCA Healthcare by 120.1% during the fourth quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock valued at $262,264,000 after purchasing an additional 476,756 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

HCA has been the topic of a number of research analyst reports. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday, April 28th. Barclays set a $416.00 target price on HCA Healthcare and gave the stock an “overweight” rating in a report on Monday, June 2nd. Guggenheim started coverage on HCA Healthcare in a report on Wednesday, April 9th. They set a “neutral” rating on the stock. Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the stock an “equal weight” rating in a report on Monday, June 9th. Finally, Robert W. Baird reissued a “neutral” rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Seven analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $392.47.

HCA Healthcare Trading Down 0.2%

Shares of NYSE HCA opened at $370.76 on Monday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The firm has a market capitalization of $89.20 billion, a PE ratio of 16.88, a PEG ratio of 1.10 and a beta of 1.49. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The business has a 50-day moving average price of $358.43 and a two-hundred day moving average price of $333.23.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm’s revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the company earned $5.36 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.78%. HCA Healthcare’s dividend payout ratio (DPR) is currently 12.81%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.